1. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
by Eduardo M. Rego, Haesook T. Kim, Guillermo J. Ruiz-Argüelles, Maria Soledad Undurraga, Maria del Rosario Uriarte, Rafael H. Jacomo, Homero Gutiérrez-Aguirre, Raul A. M. Melo, Rosane Bittencourt, Ricardo Pasquini, Katia Pagnano, Evandro M. Fagundes, Maria de Lourdes Chauffaille, Carlos S. Chiattone, Lem Martinez, Luis A. Meillón, David Gómez-Almaguer, Hau C. Kwaan, Javier Garcés-Eisele, Robert Gallagher, Charlotte M. Niemeyer, Stanley L. Schrier, Martin Tallman, David Grimwade, Arnold Ganser, Nancy Berliner, Raul C. Ribeiro, Francesco Lo-Coco, Bob Löwenberg, and Miguel A. Sanz
Blood
Volume 121(11):
March 14, 2013
©2013 by American Society of Hematology

2. Organization of the IC-APL network for the diagnosis and treatment of a given case of APL. Actions taken at the local centers are indicated in red and those taken at the national reference laboratories are indicated in blue.
Organization of the IC-APL network for the diagnosis and treatment of a given case of APL. Actions taken at the local centers are indicated in red and those taken at the national reference laboratories are indicated in blue. (A) The interaction with the panel of international experts and the educational activities are shown in yellow. (B) Geographical distribution of the IC-APL institutions.
Eduardo M. Rego et al. Blood 2013;121:
©2013 by American Society of Hematology

3. (A) OS and DSF and (B) cumulative incidence of relapse and cumulative incidence of nonrelapse mortality rates among patients with acute promyelocytic leukemia treated in the IC-APL study.
(A) OS and DSF and (B) cumulative incidence of relapse and cumulative incidence of nonrelapse mortality rates among patients with acute promyelocytic leukemia treated in the IC-APL study.
Eduardo M. Rego et al. Blood 2013;121:
©2013 by American Society of Hematology